[1. Alberici I. et al.: Pathogens causing urinary tract infections in infants: A European overview by the ESCAPE study group. Eur. J. Pediatr., 2014.10.1007/s00431-014-2459-325428232]Search in Google Scholar
[2. Bien J. et al.: Role of uropathogenic Escherichia coli virulence factors in development of urinary tract infection and kidney damage. Int. J. Nephrol., 2012, Article ID 681473, 2012. doi: 10.1155/2012/68147310.1155/2012/681473331227922506110]Search in Google Scholar
[3. Firoozeh F. et al.: Detection of virulence genes in Escherichia coli isolated from patients with cystitis and pyelonephritis. Int. J. Infect. Dis., 219, 29, 2014.10.1016/j.ijid.2014.03.139325449257]Search in Google Scholar
[4. Gupta K. et al.: International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin. Infect. Dis., e103, 52, 2011.]Search in Google Scholar
[5. Hsueh P.R. et al.: Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region. J. Infect., 114, 63, 2011.10.1016/j.jinf.2011.05.01521669223]Search in Google Scholar
[6. Huang L.F. et al.: Antimicrobial susceptibility patterns among Escherichia coli urinary isolates from community-onset health care-associated urinary tract infection. J. Form. Med. Assoc., 970, 113, 2014.10.1016/j.jfma.2014.01.00924548621]Search in Google Scholar
[7. Ironmonger D. et al.: Surveillance of antibiotic susceptibility of urinary tract pathogens for a population of 5.6 million over 4 years J. Antimicrob. Chemother., 2015.10.1093/jac/dkv04325733586]Search in Google Scholar
[8. Jacskon J. et al.: Aminoglycosides: How should we use them in the 21st century? Curr. Opin. Infect. Dis., 516, 26, 2013.10.1097/QCO.000000000000001224141453]Search in Google Scholar
[9. Jafri S.A. et al.: Antibiotic resistance of E. coli isolates from urine samples of urinary tract infection (UTI) patients in Pakistan. Bioinformation, 419, 10, 2014.10.6026/97320630010419413528925187681]Search in Google Scholar
[10. Lai B. et al.: In vitro susceptibility of Escherichia coli strains isolated from urine samples obtained in mainland China to fosfomycin trometamol and other antibiotics: A 9-year surveillance study (2004-2012). BMC Infect. Dis., 66, 14, 2014.10.1186/1471-2334-14-66392250524502648]Search in Google Scholar
[11. Leclercq R. et al.: EUCAST expert rules in antimicrobial susceptibility testing. Clin. Microbiol. Infect., 141, 19, 2013.10.1111/j.1469-0691.2011.03703.x22117544]Search in Google Scholar
[12. Udo E.E., Dashti A.A.: Detection of genes encoding aminoglycoside modifying enzymes in Staphylococci by polymerase chain reaction and dot blot hybridization. Int. J. Antimicrob. Agents, 273, 13, 2000.]Search in Google Scholar
[13. Soleimani N. et al.: Frequency distribution of genes encoding aminoglycoside modifying enzymes in uropathogenic E. coli isolated from a Iranian hospital. BMC Res. Notes, 842, 7, 2014.10.1186/1756-0500-7-842425824925424607]Search in Google Scholar
[14. Sorlozano A. et al.: Evolution of the resistance to antibiotics of bacteria involved in urinary tract infections: A 7-year surveillance study. Am. J. Infect. Control, 1033, 42, 2014.10.1016/j.ajic.2014.06.01325278389]Search in Google Scholar
[15. www.eucast.org]Search in Google Scholar